Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02637687
Title	A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children (SCOUT)
Recruitment	Active, not recruiting
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	Bayer
Indications	congenital fibrosarcoma Advanced Solid Tumor breast secretory carcinoma benign neoplasm congenital mesoblastic nephroma central nervous system cancer
Therapies	Larotrectinib
Age Groups:	adult \| child
Covered Countries	USA \| ITA \| GBR \| FRA \| ESP \| DEU \| CAN \| AUS